references
FINANCIAL REPORT
GHIT (4) (Restricted)
MOH Brazil (Restricted)
USAID (Restricted)
Bill & Melinda Médecins Sans Gates Frontières (6) Foundation (5) (Restricted/ (Restricted) Unrestricted)
Wellcome Trust (Restricted)
Medicor Foundation (Restricted)
WHO-TDR (7)
UBS OPTIMUS (Restricted)
Foundations & Other (8) (Restricted/ Unrestricted)
Financial income (Net) =
Utilization of restricted reserves
TOTAL Expenditure = 43,002,832
55,441
14,408
42,788
578,648 16,295
536,953
272,497
27,894
34,132
1,353,920
5,230,411 2,175
101,143 123,083 17,766
7,447,957 228,753 515,882 1,107 2,051,213
265,108
1,780,709
318,451 33,852 799,973 40,393 263,673 31,373 10,320 2,458 4,754 36,556 4,963 17,700 3,987 324,399
89,394
111,757
37,394 26,892 7,716 27,932
1,693,469 640,021 1,258,789 572,133 431,643 498,941 318,472
191,982 113,991
2,240,641
1,383,170
44,411
214,052
554,534
190,330
12,688
5,614,961
140,384 930,025 413,775 28,560 558 2,962 94,594 816,640
51,681
185,653
93,271 12,418
1,333,656 974,272 618,048 4,320,562 1,212,765 1,541,884 2,265,996 2,035,629 3,238,280 (160,507) (42,788) (160,507) 181,190 (61,183) 43,122,838
147,444 1,176,148 84,074 85,375 15,644 103,570 69,282 60,282 45,076 23,012 41,109 21,693 120,152 11,161 10,590 48,275 9,420 223,271 (18,395)
39,892 70,670 156,697 95,830 78,348 763,933 1,055,495 (10,380)
721,729 109,136 188,748 111,882
2,043,154
129,229
536,843
12,571,477 4,014,944
324,399
240,000
967,566
125,152
838,843
reallocated to projects funded by the donor. (6) MSF: 1) a multi-year unrestricted grant of EUR 4,000,000; 2) EUR 14,944 for the payment for services of the data management centre based in Nairobi in 2015. (7) WHO-TDR portfolio grant started in August 2015 EUR 967,566. (8) ARPE Foundation (EUR 10,000); Kalacore consortium (EUR 49,496), Rockefeller Brothers Fund (EUR 18,395); Starr International Foundation (EUR 116,503); Family Moreau (EUR 288,096); Brian Mercer Charitable Trust (EUR 13,526); FINEP- Brazil (EUR 117,212); Various individual donations from Individual donors, private foundations and corporations (EUR 170,932) mainly from North America; Royalties from Sanofi for EUR 304 earmarked for FACT activities (see note 6). In addition, DNDi in Geneva has collected various reimbursements and participation of partners throughout the year for a total of EUR 55,883 plus exceptional incomes for the year for a total of EUR17,445. (9) The restricted operating fund has been partially used (EUR 42,788) to fund and support the total expenditure attached to this project.
DNDi Annual Report 2015 › 81
